AND017

DRUG6 trials

Sponsors

Kind Pharmaceuticals LLC

Conditions

Anemia Due to Chronic Kidney DiseaseCancer-Related AnemiaChemotherapy Induced AnemiaHealthy VolunteersMyelodysplastic SyndromesRenal Anemia

Phase 1

A Food-Effect Study of AND017 in Healthy Participants

CompletedNCT04712500

Kind Pharmaceuticals LLCHealthy Volunteers

Start: 2020-07-30End: 2020-08-21Updated: 2021-05-11

Phase 2

A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

CompletedNCT05035641

Kind Pharmaceuticals LLCRenal Anemia

Start: 2021-10-18End: 2023-07-24Updated: 2023-10-04

A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy

Not yet recruitingNCT06075043

Kind Pharmaceuticals LLCCancer-Related Anemia

Start: 2027-12-01End: 2028-08-01Target: 36Updated: 2026-09-01

A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy

Not yet recruitingNCT06075030

Kind Pharmaceuticals LLCChemotherapy Induced Anemia

Start: 2027-12-01End: 2028-05-01Target: 36Updated: 2026-09-01

A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome

RecruitingNCT06304103

Kind Pharmaceuticals LLCMyelodysplastic Syndromes

Start: 2025-03-14End: 2027-05-01Target: 63Updated: 2026-02-27

Phase 3

A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)

RecruitingNCT07487727

Kind Pharmaceuticals LLCAnemia Due to Chronic Kidney Disease

Start: 2025-12-03End: 2027-07-01Target: 240Updated: 2026-03-27